The Prenatal Diagnosis and Clinical Outcomes of Fetuses With 15q11.2 Copy Number Variants: A Case Series of 36 Patients

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2021 Dec 10

PMID 34888324

Citations 2

Authors

Jessica Kang

Chien-Nan Lee

Yi-Ning Su

Ming-Wei Lin

Yi-Yun Tai

Wen-Wei Hsu

Kuan-Ying Huang

Chi-Ling Chen

Chien-Hui Hung

Shin-Yu Lin

Affiliations

Soon will be listed here.

Abstract

Prenatal genetic counseling of fetuses diagnosed with 15q11.2 copy number variants (CNVs) involving the BP1-BP2 region is difficult due to limited information and controversial opinion on prognosis. In total, we collected the data of 36 pregnant women who underwent prenatal microarray analysis from 2010 to 2017 and were assessed at National Taiwan University Hospital. Comparison of the maternal characteristics, prenatal ultrasound findings, and postnatal outcomes among the different cases involving the 15q11.2 BP1-BP2 region were presented. Out of the 36 fetuses diagnosed with CNVs involving the BP1-BP2 region, five were diagnosed with microduplications and 31 with microdeletions. Among the participants, 10 pregnant women received termination of pregnancy and 26 gave birth to healthy individuals (27 babies in total). The prognoses of 15q11.2 CNVs were controversial and recent studies have revealed its low pathogenicity. In our study, the prenatal abnormal ultrasound findings were recorded in 12 participants and were associated with 15q11.2 deletions. No obvious developmental delay or neurological disorders were detected in early childhood.

Citing Articles

Chromosome 15q11-q13 Duplication Syndrome: A Review of the Literature and 14 New Cases.

Bisba M, Malamaki C, Constantoulakis P, Vittas S Genes (Basel). 2024; 15(10).

PMID: 39457428 PMC: 11507414. DOI: 10.3390/genes15101304.

Prenatal diagnosis of fetuses with 15q11.2 BP1-BP2 microdeletion in the Chinese population: a seven-year single-center retrospective study.

Zhuang J, Zhang N, Fu W, Jiang Y, Chen Y, Chen C Mol Cytogenet. 2024; 17(1):20.

PMID: 39218907 PMC: 11367773. DOI: 10.1186/s13039-024-00690-4.

References

Abdelmoity A, LePichon J, Nyp S, Soden S, Daniel C, Yu S . 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features. J Dev Behav Pediatr. 2012; 33(7):570-6. DOI: 10.1097/DBP.0b013e31826052ae. View

Kirov G, Rees E, Walters J, Escott-Price V, Georgieva L, Richards A . The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry. 2013; 75(5):378-85. PMC: 4229045. DOI: 10.1016/j.biopsych.2013.07.022. View

Chen S, Song C, Guo H, Xu P, Huang W, Zhou Y . Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families. Hum Mutat. 2005; 25(2):135-41. DOI: 10.1002/humu.20126. View

Silva A, Kirov G, Kendall K, Bracher-Smith M, Wilkinson L, Hall J . Analysis of Diffusion Tensor Imaging Data From the UK Biobank Confirms Dosage Effect of 15q11.2 Copy Number Variation on White Matter and Shows Association With Cognition. Biol Psychiatry. 2021; 90(5):307-316. PMC: 8343146. DOI: 10.1016/j.biopsych.2021.02.969. View

Cooper G, Coe B, Girirajan S, Rosenfeld J, Vu T, Baker C . A copy number variation morbidity map of developmental delay. Nat Genet. 2011; 43(9):838-46. PMC: 3171215. DOI: 10.1038/ng.909. View

Kendall K, Bracher-Smith M, Fitzpatrick H, Lynham A, Rees E, Escott-Price V . Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank. Br J Psychiatry. 2019; 214(5):297-304. PMC: 6520248. DOI: 10.1192/bjp.2018.301. View

Chen C, Chang S, Wang L, Chang T, Chern S, Wu P . Prenatal diagnosis of a familial 15q11.2 (BP1-BP2) microdeletion encompassing TUBGCP5, CYFIP1, NIPA2 and NIPA1 in a fetus with ventriculomegaly, microcephaly and intrauterine growth restriction on prenatal ultrasound. Taiwan J Obstet Gynecol. 2018; 57(5):730-733. DOI: 10.1016/j.tjog.2018.08.022. View

Marek J, Tomek V, Skovranek J, Povysilova V, Samanek M . Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience. Heart. 2010; 97(2):124-30. DOI: 10.1136/hrt.2010.206623. View

Chen C, Lin S, Lee C, Chern S, Wu P, Chen Y . Familial transmission of recurrent 15q11.2 (BP1-BP2) microdeletion encompassing NIPA1, NIPA2, CYFIP1, and TUBGCP5 associated with phenotypic variability in developmental, speech, and motor delay. Taiwan J Obstet Gynecol. 2017; 56(1):93-97. DOI: 10.1016/j.tjog.2016.12.002. View

10.

Kalsner L, Chamberlain S . Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes. Pediatr Clin North Am. 2015; 62(3):587-606. PMC: 4449422. DOI: 10.1016/j.pcl.2015.03.004. View

11.

Davis K, Serrano M, Loddo S, Robinson C, Alesi V, Dallapiccola B . Parent-of-Origin Effects in 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome. Int J Mol Sci. 2019; 20(6). PMC: 6470921. DOI: 10.3390/ijms20061459. View

12.

Rainier S, Chai J, Tokarz D, Nicholls R, Fink J . NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet. 2003; 73(4):967-71. PMC: 1180617. DOI: 10.1086/378817. View

13.

Chu F, Shaw S, Lee C, Lo L, Hsu J, Hung T . Adverse Perinatal and Early Life Outcomes following 15q11.2 CNV Diagnosis. Genes (Basel). 2021; 12(10). PMC: 8535766. DOI: 10.3390/genes12101480. View

14.

Picinelli C, Lintas C, Piras I, Gabriele S, Sacco R, Brogna C . Recurrent 15q11.2 BP1-BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders. Am J Med Genet B Neuropsychiatr Genet. 2016; 171(8):1088-1098. DOI: 10.1002/ajmg.b.32480. View

15.

Doornbos M, Sikkema-Raddatz B, Ruijvenkamp C, Dijkhuizen T, Bijlsma E, Gijsbers A . Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet. 2009; 52(2-3):108-15. DOI: 10.1016/j.ejmg.2009.03.010. View

16.

Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S . CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2013; 505(7483):361-6. DOI: 10.1038/nature12818. View

17.

De Wolf V, Brison N, Devriendt K, Peeters H . Genetic counseling for susceptibility loci and neurodevelopmental disorders: the del15q11.2 as an example. Am J Med Genet A. 2013; 161A(11):2846-54. DOI: 10.1002/ajmg.a.36209. View

18.

Usrey K, Williams C, Dasouki M, Fairbrother L, Butler M . Congenital Arthrogryposis: An Extension of the 15q11.2 BP1-BP2 Microdeletion Syndrome?. Case Rep Genet. 2014; 2014:127258. PMC: 3978403. DOI: 10.1155/2014/127258. View

19.

Maya I, Perlman S, Shohat M, Kahana S, Yacobson S, Tenne T . Should We Report 15q11.2 BP1-BP2 Deletions and Duplications in the Prenatal Setting?. J Clin Med. 2020; 9(8). PMC: 7463673. DOI: 10.3390/jcm9082602. View

20.

Burnside R, Pasion R, Mikhail F, Carroll A, Robin N, Youngs E . Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011; 130(4):517-28. PMC: 6814187. DOI: 10.1007/s00439-011-0970-4. View